ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$19.74
arrow_downward
-1.84%(-0.37) 1D
$19.74
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$20.16
High
$20.36
Low
$19.67
Mkt. cap
3.37B
Avg. vol.
2.05M
Volume
1.67M
P/E ratio
8.92
52-wk high
$30.96
52-wk low
$19.57
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
Open
$20.16
High
$20.36
Low
$19.67
Mkt. cap
3.37B
Avg. vol.
2.05M
Volume
1.67M
P/E ratio
8.92
52-wk high
$30.96
52-wk low
$19.57
EPS
$2.21
Beta
0.89
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
AD HOC NEWS
·
14 hours ago
RBC reiterates Outperform on ACADIA Pharmaceuticals stock
Simply Wall Street
·
14 hours ago
Acadia Pharmaceuticals (ACAD) After Patent And RADIANT Updates Is The Undervalued View Too Simple
Investing.com
·
1 day ago
RBC Capital reiterates Acadia Pharmaceuticals stock rating on patent developments
GuruFocus
·
1 day ago
Acadia Pharmaceuticals (ACAD) and Zydus Move to Dismiss Patent L
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com